| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
See Remarks | Chief Medical Officer | Chief Medical Officer
1 company
Romulus K Brazzell last filed a Form 4 in October 2025, as See Remarks at KALA. From August 2017 to October 2025, the filings on record show 0 open-market purchases and 13 sales. Romulus K Brazzell's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
Historically, Romulus K Brazzell's trades have earned a strong insider score of 77/100 across 13 rated trades. Over a 12-month horizon, 76.9% of those trades were profitable, with an average 12-month return of +44.3%.
At the last filing, the largest reported position was 35,952 shares of KALA. The KALA filings lean toward selling, a net 90,013 shares.
Shares as reported in the last Form 4 for each company; the most recent is from October 2025. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 4, 2022 | KALA Kala Bio, Inc. | See Remarks | Sell | 3,504 | $1.30 | $4,555.20 | -1.2% | +0.8% | -33.7% | |
| Oct 26, 2021 | KALA Kala Bio, Inc. | Chief Medical Officer | Sell | 12,757 | $1.80 | $22,962.60 | -4.2% | -51.8% | -93.0% | |
| Jun 28, 2021 | KALA Kala Bio, Inc. | Chief Medical Officer | Sell | 3,034 | $5.77 | $17,506.18 | -1.0% | -46.6% | -93.9% |